Doctors Were Chastised For Wellbutrin Claims: GSK Exec
GlaxoSmithKline PLC worked with physicians to stop promotion of antidepressant Wellbutrin for off-label uses, a company executive testified Thursday in the Maryland trial of a former GSK attorney who allegedly obstructed...To view the full article, register now.
Already a subscriber? Click here to view full article